Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Ching

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer Genetics and Cytogenetics|July 2, 1998
A novel t(7;17)(q11;q11) as the sole karyotypic abnormality in childhood pre-B-cell acute lymphoblastic leukemiaA C Lee, S K Ma, T S Wan, et al.
British Journal of Cancer|June 27, 2002
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acidL-M Ching, Z Cao, C Kieda, et al.
Cancer Genetics and Cytogenetics|October 20, 1999
A novel t(1;10)(q32;p12) in acute myelomonocytic leukemiaT S Wan, S K Ma, L M Ching, et al.
British Journal of Cancer|August 14, 1998
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activityL M Ching, W L Browne, R Tchernegovski, et al.
Cancer Research|July 23, 1999
Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout miceL M Ching, D Goldsmith, W R Joseph, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acidL M Ching, M J McKeage, W R Joseph, et al.
Cancer Genetics and Cytogenetics|February 1, 1994
Trisomy 12 in chronic lymphocytic leukemia. An interphase cytogenetic study by fluorescence in situ hybridizationY L Kwong, J Pang, L M Ching, et al.
Cancer Genetics and Cytogenetics|September 1, 1992
Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 casesL C Chan, Y L Kwong, H W Liu, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1988
Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase IIE Schneider, S J Darkin, P A Lawson, et al.
Cancer Research|February 11, 1999
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapyW R Joseph, Z Cao, K G Mountjoy, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Genetics and Cytogenetics|July 2, 1998
A novel t(7;17)(q11;q11) as the sole karyotypic abnormality in childhood pre-B-cell acute lymphoblastic leukemiaA C Lee, S K Ma, T S Wan, et al.
British Journal of Cancer|June 27, 2002
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acidL-M Ching, Z Cao, C Kieda, et al.
Cancer Genetics and Cytogenetics|October 20, 1999
A novel t(1;10)(q32;p12) in acute myelomonocytic leukemiaT S Wan, S K Ma, L M Ching, et al.
British Journal of Cancer|August 14, 1998
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activityL M Ching, W L Browne, R Tchernegovski, et al.
Cancer Research|July 23, 1999
Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout miceL M Ching, D Goldsmith, W R Joseph, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acidL M Ching, M J McKeage, W R Joseph, et al.
Cancer Genetics and Cytogenetics|February 1, 1994
Trisomy 12 in chronic lymphocytic leukemia. An interphase cytogenetic study by fluorescence in situ hybridizationY L Kwong, J Pang, L M Ching, et al.
Cancer Genetics and Cytogenetics|September 1, 1992
Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 casesL C Chan, Y L Kwong, H W Liu, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1988
Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase IIE Schneider, S J Darkin, P A Lawson, et al.
Cancer Research|February 11, 1999
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapyW R Joseph, Z Cao, K G Mountjoy, et al.
Pageof 8